← The Wire
MLTXNasdaq
MoonLake Immunotherapeutics
Pharmaceutical Preparations · E9 · CIK 1821586
Advancing novel therapies for inflammatory skin and joint diseases by developing a tri-specific IL-17 inhibitor
red 8-K · 90d
$1.38B
Market cap
$19.91
Last close
+0.1%
1D
-10.2%
5D
1.3M
Volume
Price · last 39 sessions+13.4%
May 4L $16.37 · H $22.16Jun 29
119
Total filings
Jun 25, 2026
Last filing
12/31
Fiscal year end
SC 13GSC 13GFeb 9, 2024SC 13GSC 13GMar 31, 2023SC 13GSC 13GAug 3, 2022SC 13GSC 13GDec 10, 2021SC 13GSC 13GFeb 16, 2021SC 13GSC 13GFeb 16, 2021SC 13GSC 13GFeb 16, 2021SC 13GSC 13GFeb 8, 2021SC 13GHELIX ACQUISITION CORPNov 2, 2020SC 13GSCHEDULE 13GNov 2, 2020
Insider Activity
In the 90 days to Dec 9, 2025: 1 insider bought $99K · 3 sold $52.9M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 9, 2025 | Reich KristianChief Scientific Officer | Sell | 72,908 | $14.43 | $1.1M |
| Dec 9, 2025 | Santos Da Silva JorgeChief Executive Officer | Sell | 70,000 | $14.49 | $1.0M |
| Dec 8, 2025 | Santos Da Silva JorgeChief Executive Officer | Sell | 130,000 | $15.08 | $2.0M |
| Dec 8, 2025 | Reich KristianChief Scientific Officer | Sell | 130,000 | $15.08 | $2.0M |
| Oct 8, 2025 | Bodenstedt MatthiasChief Financial Officer | Buy | 10,870 | $9.09 | $99K |
| Sep 30, 2025 | Cormorant Global Healthcare Master Fund, LpOther | Sell | 5,827 | $6.96 | $41K |
| Sep 29, 2025 | Cormorant Global Healthcare Master Fund, LpOther | Sell | 3,390,943 | $7.58 | $25.7M |
| Sep 29, 2025 | Cormorant Global Healthcare Master Fund, LpOther | Sell | 2,800,000 | $6.61 | $18.5M |
| Sep 29, 2025 | Cormorant Global Healthcare Master Fund, LpOther | Sell | 232,460 | $8.40 | $2.0M |
| Sep 29, 2025 | Cormorant Global Healthcare Master Fund, LpOther | Sell | 70,748 | $9.38 | $664K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance